Biocorrx Inc. (OTCMKTS:BICX – Get Free Report) passed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $0.37 and traded as low as $0.34. Biocorrx shares last traded at $0.34, with a volume of 750 shares traded.
Biocorrx Stock Down 15.0%
The firm’s 50 day moving average price is $0.37 and its two-hundred day moving average price is $0.35. The firm has a market capitalization of $10.03 million, a PE ratio of -2.12 and a beta of 0.17.
Biocorrx (OTCMKTS:BICX – Get Free Report) last released its quarterly earnings results on Friday, May 15th. The company reported ($0.03) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.06) by $0.03. The firm had revenue of $0.21 million for the quarter, compared to analysts’ expectations of $0.22 million.
About Biocorrx
BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.
Recommended Stories
- Five stocks we like better than Biocorrx
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
Receive News & Ratings for Biocorrx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biocorrx and related companies with MarketBeat.com's FREE daily email newsletter.
